Intervention Review

Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion

  1. David A Henry1,*,
  2. Paul A Carless2,
  3. Annette J Moxey3,
  4. Dianne O'Connell4,
  5. Barrie J Stokes2,
  6. Dean A Fergusson5,
  7. Katharine Ker6

Editorial Group: Cochrane Injuries Group

Published Online: 16 MAR 2011

Assessed as up-to-date: 31 JAN 2010

DOI: 10.1002/14651858.CD001886.pub4

How to Cite

Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, Ker K. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews 2011, Issue 3. Art. No.: CD001886. DOI: 10.1002/14651858.CD001886.pub4.

Author Information

  1. 1

    Institute of Clinical Evaluative Sciences, Toronto, Ontario, Canada

  2. 2

    Faculty of Health, University of Newcastle, Discipline of Clinical Pharmacology, Newcastle, New South Wales, Australia

  3. 3

    Faculty of Health, University of Newcastle, Research Centre for Gender, Health & Ageing, Newcastle, New South Wales, Australia

  4. 4

    Cancer Council, Cancer Epidemiology Research Unit, Sydney, NSW, Australia

  5. 5

    University of Ottawa Centre for Transfusion Research, Ottawa Health Research Institute, Ottawa, Ontario, Canada

  6. 6

    London School of Hygiene & Tropical Medicine, Cochrane Injuries Group, London, UK

*David A Henry, Institute of Clinical Evaluative Sciences, 2075 Bayview Avenue, G1 06, Toronto, Ontario, M4N 3M5, Canada. david.henry@ices.on.ca.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 16 MAR 2011

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Deborah M. Siegal, Adam Cuker, Reversal of novel oral anticoagulants in patients with major bleeding, Journal of Thrombosis and Thrombolysis, 2013, 35, 3, 391

    CrossRef